Basildon University Hospital has been rated inadequate for its maternity services and given a formal warning after an […]
Category: Uncategorized
The move will expand Janssen’s presence in autoimmune diseases
The approval broadens the drug’s label to include fifth treatment option in the relapsed/refractory multiple myeloma setting
The free event will discuss key insights into achieving impactful patient partnerships and advocacy
The treatment, developed by UCL clinicians, allows for surgery and radiation therapy at the same time
Trusts should aim to recruit at least 60% of eligible COVID-19 patients into trials
Updated Date: Thu, 13 Aug 2020 00:00:00 EDT
Novartis gets a green light to challenge Roche, Sanofi with delayed MS med Kesimpta chelfand Thu, 08/20/2020 – […]
The government has announced that it will lift the cap on the number of medical school places in […]
